Device to close an irregular heartbeat heart pocket safely
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests the Zenith system, a device that seals off a heart area called the left atrial appendage to reduce stroke risk in people with atrial fibrillation (AF). You may be eligible if you have AF and a doctor recommends LAA closure, and you can return for follow-up scans and visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old when you are screened
- Have a confirmed diagnosis of non-valvular atrial fibrillation (AF)
- Have a doctor’s reason to get left atrial appendage (LAA) closure
- Be willing and able to come back for scheduled follow-up visits and tests
- Be able and willing to sign informed consent (agree to join after learning the risks)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to close off a small pouch in the heart called the left atrial appendage, which is a common source of blood clots in people with atrial fibrillation. The goal is to lower your stroke risk without needing to take blood thinners long-term.
This study tests a procedure that seals off the left atrial appendage (a small heart pouch) to help prevent stroke in people with atrial fibrillation. You may be considered if your stroke risk is high and you are already on blood-thinner medicine.
This study tests whether closing a heart pouch called the left atrial appendage can prevent future strokes in people with atrial fibrillation who had an ischemic stroke even while taking blood thinners. It may help reduce stroke risk by blocking a common place where clotting can start.
This study tests a procedure called left atrial appendage occlusion. It blocks off a small pouch in the heart where blood clots can form, to reduce stroke risk without needing long-term blood thinners. This might help kidney dialysis patients who have atrial fibrillation, even though they are on dialysis.
This trial tests a new device called ENDOMATIC SEPIOLA that closes a small pouch in your heart (the left atrial appendage) to lower your stroke risk. It is a non-surgical option for people with atrial fibrillation who cannot take blood thinners.
This trial tests a device that closes off a small pouch in the heart where blood clots can form in people with atrial fibrillation. This may help reduce the risk of stroke without needing long-term blood thinners.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.